Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
4.520
+0.390 (9.44%)
At close: May 12, 2025, 4:00 PM
4.837
+0.317 (7.01%)
After-hours: May 12, 2025, 7:08 PM EDT
Health Catalyst Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 8.00, with a low estimate of 4.00 and a high estimate of 16. The average target predicts an increase of 76.99% from the current stock price of 4.52.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Health Catalyst stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 5 | 6 | 6 | 6 | 5 | 5 |
| Hold | 3 | 2 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +99.12% | May 8, 2025 |
| Stifel | Stifel | Hold Maintains $5 → $5.5 | Hold | Maintains | $5 → $5.5 | +21.68% | May 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.5 | Strong Buy | Maintains | $7 → $6.5 | +43.81% | Apr 25, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +10.62% | Apr 16, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $6 → $4 | Buy → Hold | Downgrades | $6 → $4 | -11.50% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
340.86M
from 306.58M
Increased by 11.18%
Revenue Next Year
374.06M
from 340.86M
Increased by 9.74%
EPS This Year
0.30
from -1.15
EPS Next Year
0.43
from 0.30
Increased by 43.27%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 352.1M | 398.0M | 436.5M | |
| Avg | 340.9M | 374.1M | 413.4M | |
| Low | 323.5M | 345.6M | 390.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 14.8% | 16.7% | 16.7% | |
| Avg | 11.2% | 9.7% | 10.5% | |
| Low | 5.5% | 1.4% | 4.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.47 | 0.68 | 1.00 | |
| Avg | 0.30 | 0.43 | 0.72 | |
| Low | 0.21 | 0.32 | 0.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 125.7% | 131.6% | |
| Avg | - | 43.3% | 67.7% | |
| Low | - | 7.6% | 32.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.